Resources
About Us
Meticulous Research®—a leading global market research company, published a research report titled, ‘In Vitro Diagnostics (IVD) Market—Global Opportunity Analysis and Industry Forecast (2024-2031)’. According to this latest publication from Meticulous Research®, the global in vitro diagnostics market is expected to register a CAGR of 5.3% from 2024 to reach $116.28 billion by 2031.
The growth of the global in vitro diagnostics market is driven by the increasing chronic disease prevalence and elderly population, the rise of infectious ailments, growing research funding, increasing awareness of early disease diagnosis, the rising need for point-of-care (POC) diagnostics for faster diagnosis, and growing healthcare expenditure. Furthermore, the high scope for market expansion in developing countries, increasing preference for personalized medicine, and advanced genomics & proteomics modalities create substantial growth opportunities for the IVD market players.
However, watertight technical and regulatory requisites for high/moderate-complexity tests and varying test results of rapid IVD are expected to hinder the growth of this market. The changing regulatory scenarios pose a significant challenge to the market growth.
Key Players
The key players operating in the global in vitro diagnostics market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Wama Diagnostica (Brazil), Wiener Laboratorios SAIC (Argentina), Ortho-Clinical Diagnostics, Inc. (U.S.), Agilent Technologies Inc. (U.S.), DiaSorin S.p.A. (Italy), Hologic, Inc. (U.S.), Abcam Plc (U.K.), Raybiotech, Inc. (U.S.), Oy Medix Biochemica Ab (Finland), InBios International, Inc. (U.S.), Dextra Laboratories Ltd. (U.K.), Genecopoeia, Inc. (U.S.), Sakura Finetek USA, Inc. (U.S.), and Edvotek, Inc. (U.S.).
Global In Vitro Diagnostics Market: Future Outlook
The global in vitro diagnostics market is segmented based on offering, technology, application, diagnostic approach, and end user. The study also evaluates industry competitors and analyzes their market share at the global and regional levels.
By offering, the reagents & kits segment is predicted to hold the largest market share of 81.1% in 2024. This segment’s major market share is due to the recurring use of assays & kits in identifying the causes of various chronic conditions, the wide availability of reagents & consumables for disease diagnosis, and the high implementation of self-testing kits in emerging economies. In addition, key market players are focusing on various growth strategies, such as product launches and strategic agreements, to strengthen their market positions. For instance, in May 2022, QIAGEN N.V. (Netherlands) launched the therascreen EGFR RGQ PCR Kit, a new in vitro diagnostic test for sensitive EGFR mutation analysis. This kit detects all currently known activating and resistance EGFR mutations.
By technology, the molecular diagnostics segment is expected to dominate in 2024, with a 23.1% share in the IVD market. This segment's large market share is attributed to the rising incidence of infectious diseases and the growing use of DNA, RNA, and protein analysis for disease diagnosis. Advancements in automated instrument systems are leading to accurate delivery of results through PCR and other molecular technologies, contributing to the segment's growth.
By application, in 2024, the infectious diseases segment is anticipated to hold a major share of 37.8% in the IVD market. This large market share is attributed to increasing government initiatives to promote awareness regarding testing and early diagnosis and the outbreak of infectious worldwide.
By diagnostic approach, the lab testing segment is slated to record the largest share of the in vitro diagnostics market in 2024. This segment's large market share is due to the accessibility of a trained workforce and a broad range of tests for diagnosing various diseases and conditions in laboratory settings.
By end user, in 2024, the hospitals & clinics segment is projected to make up for the largest share of the in vitro diagnostics market. The large market share of this segment is attributed to the rise in laboratory automation, the availability of well-equipped systems, a shortage of skilled labor, the growing prevalence of infectious diseases, and increasing government initiatives aimed at improving healthcare infrastructure.
This research report analyzes major geographies and provides a comprehensive analysis of the market in North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and the Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), and the Middle East (Saudi Arabia and Rest of Middle East), and Africa (South Africa and Rest of Africa).
By geography, North America is anticipated to hold the dominant position in 2024, with a share of 37.5% of the in vitro diagnostics market. North America's large market share is attributed to the high prevalence of chronic and infectious conditions in the region, increasing understanding and acceptance from people for early disease diagnosis, rising utilization of advanced diagnostic products, and increasing number of funding initiatives coupled with novel developments in diagnostic technologies.
Download Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=4858
Key Questions Answered in the Report:
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Bakuchiol Serum Market to Reach $4.41 Million by 2031
Read MoreBurn Care Market to be Worth $4.32 Billion by 2031
Read MoreAfrica Medical Devices Market to be Worth $7.14 Billion by 2031
Read MoreMiddle East Medical Devices Market to be Worth $8.8 Billion by 2031
Read MoreSurgical Drills Market to be Worth $1.71 Billion by 2031
Read MoreTissue Engineering Market to reach $7.41 Billion by 2031
Read MoreDental Prosthetics Market to be Worth $ 19.6 Billion by 2031
Read MoreWhole Genome Sequencing Market to be Worth $7.17 Billion by 2031
Read MoreIVD Assay Development Market to be Worth $8.39 Billion by 2031
Read MoreNeurogenomics Market to Reach $4.68 Billion by 2031
Read MoreIndia VNA & PACS Market to Reach $341.6 Million by 2031
Read MoreChina Microarray Market to Be Worth $910.4 Million by 2031
Read MoreChina Neurogenomics Market to Reach $562.1 Million by 2031
Read MoreELISA Market to be Worth $32.69 Billion by 2031
Read MoreDNA Sequencing Market to be Worth $21.30 Billion by 2031
Read MoreOral Care Market to be Worth $58.99 Billion by 2031
Read MoreSpirometer Market to be Worth $1.80 Billion by 2031
Read MoreViral Vaccines Market to be Worth $64.18 Billion by 2031
Read MorePet Care Market to be Worth $287.96 Billion by 2031
Read MoreRegenerative Medicine Market to be Worth $37.27 Billion by 2031
Read MoreHemostats Market to be Worth $5.32 Billion by 2031
Read MoreBioreactors Market to be Worth $39.96 Billion by 2031
Read MoreProtein Assays Market to be Worth $4.36 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreAsia-Pacific NGS Automation Market to be Worth $371 Million by 2031
Read MoreLatin America NGS Market to be Worth $765.2 Million by 2031
Read MoreBiochemical Reagents Market to be Worth $39.61 Billion by 2031
Read MoreMicroarray Kits Market to be Worth $2.51 Billion by 2031
Read MoreAntibody Production Market to Reach $58.35 Billion by 2031
Read MoreMiddle East IVD Market to be Worth $2.15 Billion by 2031
Read MoreSpatial Genomics Market to be Worth $3.23 Billion by 2031
Read MoreAsia-Pacific IVD Market to be Worth $36.02 Billion by 2031
Read MoreEurope NGS Market to be Worth $6.40 Billion by 2030
Read MoreLab Automation Market to be Worth $11.31 Billion by 2031
Read MoreBioinformatics Market to Reach $31.71 Billion by 2031
Read MoreEurope IVD Market to be Worth $39.77 Billion by 2030
Read MoreSequencing Kits Market to be Worth $25.29 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreU.S. Ambulatory EHR Market to be Worth $3.97 Billion by 2031
Read MoreSample Preparation Market to be Worth $12.77 Billion by 2031
Read MoreSurgical Robots Market Worth $25.47 Billion by 2030
Read MoreMedical Coatings Market Worth $3.32 Billion by 2030
Read MoreDigital Therapeutics Market to be Worth $56.34 Billion by 2031
Read MoreLiquid Handling Systems Market Worth $6.99 Billion by 2029
Read MoreElectrosurgery Market to be Worth $8.99 Billion by 2031
Read MoreRadiation Dose Management Market Worth $749.1 Million by 2029
Read MoreMolecular Diagnostics Market Worth $46.69 Billion by 2030
Read MoreNewborn Screening Market to be Worth $2.69 Billion by 2031
Read MorePharmacogenomics Market to be Worth $19.5 Billion by 2031
Read MoreDental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read MoreNepal IVD Market Worth $62.7 Million by 2029
Read MorePharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read MoreIndonesia IVD Market Worth $1.11 Billion by 2029
Read MoreMedical Waste Management Market Worth $17.02 billion by 2030
Read MoreEmpty Capsules Market Worth $4.47 Billion by 2029
Read MoreClear Aligners Market to be worth $18.8 Billion by 2030
Read MoreHLA Typing Market Worth $1.9 Billion by 2029
Read MoreReal-world Data Market Worth $1.66 billion by 2029
Read MoreTrack and Trace Solutions Market Worth $27.27 billion by 2029
Read MoreSurface Disinfectant Market Worth $9.52 Billion by 2029
Read MoreElectronic Lab Notebook Market Worth $787.7 million by 2029
Read MoreRapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read MorePlasma Therapy Market Worth $882.5 Million by 2028
Read MorePeripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read MoreBiomaterials Market to Reach 128.7 Billion USD by 2023
Read MoreVaccine Storage Equipment Market Worth $1.83 billion by 2027
Read MorePlasma Fractionation Market Worth $46.9 Billion by 2029
Read MoreHome Healthcare Market to be Worth $514.5 Billion by 2030
Read MoreCardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read MoreEuropean Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read MoreCompetent Cells Market Worth 2,318.6 Million USD By 2023
Read MoreCancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read MoreMultimodal Imaging Market Worth $1.6 Billion By 2024
Read MorePulse Lavage Market to be Worth $661.1 Million by 2030
Read MoreMedical Cooling Systems Market Worth $2.8 Billion By 2024
Read MoreTissue Diagnostics Market Worth $8.52 Billion by 2029
Read MoreEndoscopy Equipment Market Worth $59.8 Billion by 2029
Read MoreAfrican Forensic DNA Testing Market Worth $136.3 Million by 2025
Read MoreClinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read MoreInfection Control Market Worth $58.2 Billion by 2027
Read MoreSleep Apnea Devices Market Worth $12.9 billion by 2027
Read MoreMedical 3D Printing Market To Reach $983.2 Million By 2020
Read MoreGenomics Market to be Worth $70.52 Billion by 2031
Read MoreAnalytical Standards Market Worth $2.66 Billion By 2027
Read MoreTelehealth Market Worth $539.73 Billion by 2029
Read MoreCell Culture Market Worth $48.63 Billion by 2029
Read MoreAntimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read MoreFlow Cytometry Market Worth $6.4 Billion by 2027
Read MoreMedical Aesthetics Market Worth $29.43 billion by 2029
Read MoreOligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read MoreIn Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read MoreDental Implants Market Worth $6.52 Billion by 2029
Read MoreActive Implantable Devices Market Worth 24.02 Billion USD By 2022
Read MoreVentilators Market to be Worth $13.23 Billion by 2031
Read MoreDialysis Market to be Worth $36.6 Billion by 2031
Read MorePlasmapheresis Market to be Worth $2.55 Billion by 2030
Read MoreDiabetes Care Devices Market Worth $31.9 Billion by 2028
Read MoreClinical Genomics Market Worth 879.0 Million USD By 2023
Read MoreIVD Quality Control Market to be Worth $2.28 Billion by 2031
Read MoreLaboratory Informatics Market Worth $6.1 Billion by 2030
Read MoreChromatography Data Systems Market to be Worth $1.7 billion by 2030
Read MoreBone Growth Stimulators Market Worth $1.94 Billion by 2030
Read MoreDigital Diabetes Market worth $12.03 billion by 2025
Read MoreTrocars Market Worth $968.5 Million by 2024
Read MoreHealthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read MoreEurope Hospital Beds Market to be Worth $2.09 Billion by 2030
Read MoreImmunoassay Market Worth $46.49 Billion by 2028
Read MoreHospital Beds Market to Reach $7.09 Billion by 2031
Read MoreUrinalysis Market Worth $2.19 billion by 2027
Read MoreMedical Image Management Market Worth $7.22 billion by 2030
Read MoreBreast Imaging Market Worth $7.08 Billion by 2027
Read MoreVNA & PACS Market to be Worth $6.50 Billion by 2031
Read More